Home
News
Interviews
Companies
Videos
Markets
Subscribe
The
Latest
The Latest
News
MINDCURE Announces Participation at Upcoming Events in November 2021
News
Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials
News
Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin
News
PharmaTher Provides Business Update and Releases Financial Results for the First Quarter of Fiscal 2022
More Articles
FEATURED
William (Bill) J. Ciprick | CEO, Optimi Health
News
Clearmind Signs Development and Supply Agreement to Produce Its Drug Candidate MEAI Psychedelic Molecule With Aragen Life Sciences
News
World Leading Drug Delivery Researcher Professor Ryan Donnelly Joins PharmaTher as Scientific and Technical Advisor
Trending
#
News
Algernon Files Meeting Request with MHRA for Use of DMT in Phase 1/2a Human Stroke Study
#
News
Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
#
News
Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities
#
News
Lobe Sciences Announces Data Demonstrating That Its Combination Therapeutic Candidates are Significantly More Effective Than Monotherapy in mTBI and PTSD
#
News
Pure Extracts and Psyence Group Form Joint Venture for Psychedelic Medicinal Mushroom Extracts
Companies
#
Tryp Therapeutics
NEO
NASDAQ
CSE
TSXV
Private Company
#
Cybin Inc.
NEO
NASDAQ
CSE
TSXV
Private Company
#
Field Trip Health
NEO
NASDAQ
CSE
TSXV
Private Company
#
Numinus
NEO
NASDAQ
CSE
TSXV
Private Company
#
Mydecine Innovations Group
NEO
NASDAQ
CSE
TSXV
Private Company
